Correlation Between Spyre Therapeutics and Direct Line
Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and Direct Line at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and Direct Line into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spyre Therapeutics and Direct Line Insurance, you can compare the effects of market volatilities on Spyre Therapeutics and Direct Line and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of Direct Line. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and Direct Line.
Diversification Opportunities for Spyre Therapeutics and Direct Line
-0.26 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Spyre and Direct is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and Direct Line Insurance in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Direct Line Insurance and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with Direct Line. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Direct Line Insurance has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and Direct Line go up and down completely randomly.
Pair Corralation between Spyre Therapeutics and Direct Line
Given the investment horizon of 90 days Spyre Therapeutics is expected to under-perform the Direct Line. But the stock apears to be less risky and, when comparing its historical volatility, Spyre Therapeutics is 2.76 times less risky than Direct Line. The stock trades about -0.27 of its potential returns per unit of risk. The Direct Line Insurance is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest 864.00 in Direct Line Insurance on September 4, 2024 and sell it today you would earn a total of 303.00 from holding Direct Line Insurance or generate 35.07% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Spyre Therapeutics vs. Direct Line Insurance
Performance |
| Timeline |
| Spyre Therapeutics |
| Direct Line Insurance |
Spyre Therapeutics and Direct Line Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Spyre Therapeutics and Direct Line
The main advantage of trading using opposite Spyre Therapeutics and Direct Line positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, Direct Line can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Direct Line will offset losses from the drop in Direct Line's long position.| Spyre Therapeutics vs. RBC Bearings Incorporated | Spyre Therapeutics vs. Newpark Resources | Spyre Therapeutics vs. The Wendys Co | Spyre Therapeutics vs. Park Hotels Resorts |
| Direct Line vs. MACOM Technology Solutions | Direct Line vs. Kulicke and Soffa | Direct Line vs. Delek Drilling | Direct Line vs. Entegris |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |